REGENXBIO raises $100M in equity offering
REGENXBIO priced an underwritten public offering of about 10M common shares at $9.00 each and 1.11M pre-funded warrants at $8.9999 apiece.
The offering is expected to generate gross proceeds of approximately $100M before fees and expenses.
This move comes as the company seeks to raise capital through the sale of its common shares and pre-funded warrants.